Concepedia
Statistics
Publications
6
Citations
138
H-Index
Active since
2021
Affiliations
Université de Bourgogne(Current)
Inserm
Genomic and Immunotherapy Medical Institute
Centre Georges François Leclerc
Maison des Sciences sociales et des Humanités de Dijon
Julie Lecuelle is an author at Université de Bourgogne specializing in oncology, medicine, and immune checkpoint regulation.
Publications per year
2021–2022
Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing
Loïck Galland, Elise Ballot, Hugo Mananet et al. · npj Breast Cancer · 2022 · 36 citations · Full text
Medicine, Molecular Genetics, Oncology +17
Prognostic value of Thyroid Transcription Factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1
Loïck Galland, Anne Laure Le Page, Julie Lecuelle et al. · OncoImmunology · 2021 · 29 citations · Full text
Medicine, Immunology, Oncology +17
Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer
Loïck Galland, Julie Lecuelle, Laure Favier et al. · Cancers · 2021 · 28 citations · Full text
MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer
Julie Lecuelle, Laure Favier, Cléa Fraisse et al. · Journal for ImmunoTherapy of Cancer · 2022 · 20 citations · Full text
Medicine, Cancer Biology, Oncology +17
Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer
Valentin Dérangère, Julie Lecuelle, Côme Lepage et al. · European Journal of Cancer · 2022 · 15 citations
Medicine, Clinical Sciences, Oncology +10
1–5 of 6